Proto Labs Inc (PRLB) stock
PRLBNYSEFabricated Structural Metal ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3048% above fair value
$69.11+1.18 (+1.74%)
Close on Nov 11, 2026Market cap $1.65BP/E 48.3Yield –
Earnings
Proto Labs's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 5, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$154.30M
+14.0% on a year earlier
Non-GAAP net income per diluted share, Q3 FY2026
$0.63
$0.47 a year earlier
Latest guidance
Issued
Oct 29, 2026 · 4 items
Quarterly results
Revenue and earnings per share from each of Proto Labs's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 5, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 29, 2026before the open | $154.30M | +14.0% | $0.48 | $0.63 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 31, 2026before the open | $149.30M | +10.5% | $0.37 | $0.60 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 1, 2026before the open | $139.30M | +10.4% | $0.33 | $0.54 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 6, 2026before the open | $136.50M | +12.1% | $0.25 | $0.44 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 31, 2025before the open | $135.40M | +7.8% | $0.30 | $0.47 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 31, 2025before the open | $135.10M | +7.6% | $0.18 | $0.41 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 2, 2025before the open | $126.20M | -1.3% | $0.15 | $0.33 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 7, 2025before the open | $121.80M | -2.6% | -$0.02 | $0.38 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 1, 2024before the open | $125.60M | -3.9% | $0.29 | $0.47 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 2, 2024before the open | $125.60M | +2.7% | $0.18 | $0.38 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 3, 2024before the open | $127.90M | +1.6% | $0.20 | $0.40 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 9, 2024before the open | $125.00M | +8.1% | $0.27 | $0.46 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 3, 2023before the open | $130.70M | +7.4% | $0.31 | $0.51 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 4, 2023before the open | $122.30M | -3.6% | -$0.01 | $0.33 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 5, 2023before the open | $125.90M | +1.4% | $0.10 | $0.30 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 10, 2023before the open | $115.60M | -6.5% | -$4.24 | $0.26 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 4, 2022before the open | $121.70M | -2.9% | $0.14 | $0.40 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 5, 2022before the open | $126.90M | – | $0.09 | $0.46 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 6, 2022before the open | $124.20M | – | $0.19 | $0.38 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 11, 2022before the open | $123.60M | – | $0.43 | $0.41 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 28, 2021before the open | $125.30M | – | $0.17 | $0.35 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 29, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 6, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 12, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 29, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Proto Labs's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| revenue | Q4 FY2026 | $143.00M – $151.00M | – | New | Oct 29, 2026 |
| GAAP diluted net income per shareGAAP | Q4 FY2026 | $0.28 – $0.36 | – | New | Oct 29, 2026 |
| non-GAAP diluted net income per sharenon-GAAP | Q4 FY2026 | $0.46 – $0.54 | – | New | Oct 29, 2026 |
| revenue growth | FY2026 | +10% – +11% | – | New | Oct 29, 2026 |
| revenue growth | FY2026 | +8% – +10% | +6% – +8% | Raised | Jul 31, 2026 |
Guidance vs results
The last range Proto Labs gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | EPS (GAAP) | $0.34 – $0.42 | $0.48 | Above range |
| Q3 FY2026 | non-GAAP diluted net income per share | $0.56 – $0.64 | $0.63 | Within range |
| Q3 FY2026 | Revenue | $145.00M – $153.00M | $154.30M | Above range |
| Q2 FY2026 | EPS (GAAP) | $0.29 – $0.37 | $0.37 | Within range |
| Q2 FY2026 | non-GAAP diluted net income per share | $0.50 – $0.58 | $0.60 | Above range |
| Q2 FY2026 | Revenue | $140.00M – $148.00M | $149.30M | Above range |
| Q1 FY2026 | EPS (GAAP) | $0.17 – $0.25 | $0.33 | Above range |
| Q1 FY2026 | non-GAAP diluted net income per share | $0.36 – $0.44 | $0.54 | Above range |
| Q1 FY2026 | Revenue | $130.00M – $138.00M | $139.30M | Above range |
| Q4 FY2025 | EPS (GAAP) | $0.12 – $0.20 | $0.25 | Above range |
| Q4 FY2025 | non-GAAP diluted net income per share | $0.30 – $0.38 | $0.44 | Above range |
| Q4 FY2025 | Revenue | $125.00M – $133.00M | $136.50M | Above range |
| Q3 FY2025 | EPS (GAAP) | $0.17 – $0.25 | $0.30 | Above range |
| Q3 FY2025 | non-GAAP diluted net income per share | $0.35 – $0.43 | $0.47 | Above range |
| Q3 FY2025 | Revenue | $130.00M – $138.00M | $135.40M | Within range |
| Q2 FY2025 | EPS (GAAP) | $0.11 – $0.19 | $0.18 | Within range |
| Q2 FY2025 | non-GAAP diluted net income per share | $0.30 – $0.38 | $0.41 | Above range |
| Q2 FY2025 | Revenue | $124.00M – $132.00M | $135.10M | Above range |
| Q1 FY2025 | EPS (GAAP) | $0.08 – $0.16 | $0.15 | Within range |
| Q1 FY2025 | non-GAAP diluted net income per share | $0.26 – $0.34 | $0.33 | Within range |
| Q1 FY2025 | Revenue | $120.00M – $128.00M | $126.20M | Within range |
| Q4 FY2024 | EPS (GAAP) | $0.10 – $0.18 | -$0.02 | Below range |
| Q4 FY2024 | non-GAAP diluted net income per share | $0.28 – $0.36 | $0.38 | Above range |
| Q4 FY2024 | Revenue | $115.00M – $123.00M | $121.80M | Within range |
| Q3 FY2024 | EPS (GAAP) | $0.10 – $0.18 | $0.29 | Above range |
| Q3 FY2024 | non-GAAP diluted net income per share | $0.29 – $0.37 | $0.47 | Above range |
| Q3 FY2024 | Revenue | $117.00M – $125.00M | $125.60M | Above range |
| Q2 FY2024 | EPS (GAAP) | $0.11 – $0.19 | $0.18 | Within range |
| Q2 FY2024 | non-GAAP diluted net income per share | $0.30 – $0.38 | $0.38 | Within range |
| Q2 FY2024 | Revenue | $122.00M – $130.00M | $125.60M | Within range |
| Q1 FY2024 | EPS (GAAP) | $0.09 – $0.17 | $0.20 | Above range |
| Q1 FY2024 | non-GAAP diluted net income per share | $0.26 – $0.34 | $0.40 | Above range |
| Q1 FY2024 | Revenue | $120.00M – $128.00M | $127.90M | Within range |
Guidance history
Every forecast Proto Labs put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 29, 2026 | non-GAAP diluted net income per share | Q4 FY2026 | $0.46 – $0.54 | New |
| Oct 29, 2026 | GAAP diluted net income per share | Q4 FY2026 | $0.28 – $0.36 | New |
| Oct 29, 2026 | revenue | Q4 FY2026 | $143.00M – $151.00M | New |
| Oct 29, 2026 | revenue growth | FY2026 | +10% – +11% | New |
| Jul 31, 2026 | non-GAAP diluted net income per share | Q3 FY2026 | $0.56 – $0.64 | New |
| Jul 31, 2026 | GAAP diluted net income per share | Q3 FY2026 | $0.34 – $0.42 | New |
| Jul 31, 2026 | revenue growth | FY2026 | +8% – +10% | Raised |
| Jul 31, 2026 | revenue | Q3 FY2026 | $145.00M – $153.00M | New |
| May 1, 2026 | non-GAAP diluted net income per share | Q2 FY2026 | $0.50 – $0.58 | New |
| May 1, 2026 | diluted net income per share | Q2 FY2026 | $0.29 – $0.37 | New |
| May 1, 2026 | revenue growth | FY2026 | +6% – +8% | Reaffirmed |
| May 1, 2026 | revenue | Q2 FY2026 | $140.00M – $148.00M | New |
| Feb 6, 2026 | non-GAAP diluted net income per share | Q1 FY2026 | $0.36 – $0.44 | New |
| Feb 6, 2026 | diluted net income per share | Q1 FY2026 | $0.17 – $0.25 | New |
| Feb 6, 2026 | revenue growth | FY2026 | +6% – +8% | New |
| Feb 6, 2026 | revenue | Q1 FY2026 | $130.00M – $138.00M | New |
| Oct 31, 2025 | non-GAAP diluted net income per share | Q4 FY2025 | $0.30 – $0.38 | New |
| Oct 31, 2025 | diluted net income per share | Q4 FY2025 | $0.12 – $0.20 | New |
| Oct 31, 2025 | revenue | Q4 FY2025 | $125.00M – $133.00M | New |
| Jul 31, 2025 | non-GAAP diluted net income per share | Q3 FY2025 | $0.35 – $0.43 | New |
| Jul 31, 2025 | diluted net income per share | Q3 FY2025 | $0.17 – $0.25 | New |
| Jul 31, 2025 | revenue | Q3 FY2025 | $130.00M – $138.00M | New |
| May 2, 2025 | non-GAAP diluted net income per share | Q2 FY2025 | $0.30 – $0.38 | New |
| May 2, 2025 | diluted net income per share | Q2 FY2025 | $0.11 – $0.19 | New |
| May 2, 2025 | revenue | Q2 FY2025 | $124.00M – $132.00M | New |
| Feb 7, 2025 | non-GAAP diluted net income per share | Q1 FY2025 | $0.26 – $0.34 | New |
| Feb 7, 2025 | diluted net income per share | Q1 FY2025 | $0.08 – $0.16 | New |
| Feb 7, 2025 | revenue | Q1 FY2025 | $120.00M – $128.00M | New |
| Nov 1, 2024 | non-GAAP diluted net income per share | Q4 FY2024 | $0.28 – $0.36 | New |
| Nov 1, 2024 | diluted net income per share | Q4 FY2024 | $0.10 – $0.18 | New |
| Nov 1, 2024 | revenue | Q4 FY2024 | $115.00M – $123.00M | New |
| Aug 2, 2024 | non-GAAP diluted net income per share | Q3 FY2024 | $0.29 – $0.37 | New |
| Aug 2, 2024 | diluted net income per share | Q3 FY2024 | $0.10 – $0.18 | New |
| Aug 2, 2024 | revenue | Q3 FY2024 | $117.00M – $125.00M | New |
| May 3, 2024 | non-GAAP diluted net income per share | Q2 FY2024 | $0.30 – $0.38 | New |
| May 3, 2024 | diluted net income per share | Q2 FY2024 | $0.11 – $0.19 | New |
| May 3, 2024 | revenue | Q2 FY2024 | $122.00M – $130.00M | New |
| Feb 9, 2024 | non-GAAP diluted net income per share | Q1 FY2024 | $0.26 – $0.34 | New |
| Feb 9, 2024 | diluted net income per share | Q1 FY2024 | $0.09 – $0.17 | New |
| Feb 9, 2024 | revenue | Q1 FY2024 | $120.00M – $128.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Proto Labs filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Update
- Results
- Results
- Results
- Update
- Results
- Update
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?